These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38352096)

  • 1. Pembrolizumab-Induced Isolated Adrenocorticotropic Hormone (ACTH) Deficiency
.
    Alfares K; Han HJ
    Cureus; 2024 Jan; 16(1):e52235. PubMed ID: 38352096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated ACTH deficiency during single-agent pembrolizumab for squamous cell lung carcinoma: a case report.
    Tanaka S; Kushimoto M; Nishizawa T; Takubo M; Mitsuke K; Ikeda J; Fujishiro M; Ogawa K; Tsujino I; Suzuki Y; Abe M
    Clin Diabetes Endocrinol; 2020; 6():1. PubMed ID: 31921440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].
    Gu YC; Liu Y; Xie C; Cao BS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):369-375. PubMed ID: 35435206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pembrolizumab-induced secondary adrenal insufficiency due to adrenocorticotrophic hormone deficiency in a patient with non-small-cell lung carcinoma: a case report.
    Fujimiya T; Azuma K; Togashi Y; Kuwata K; Unezaki S; Takeuchi H
    J Pharm Health Care Sci; 2024 Feb; 10(1):10. PubMed ID: 38365819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non-small-cell lung cancer.
    Kurokawa K; Mitsuishi Y; Shimada N; Ito N; Ogiwara M; Miura K; Asao T; Ko R; Shukuya T; Shibayama R; Goto H; Takahashi K
    Thorac Cancer; 2023 Feb; 14(5):442-449. PubMed ID: 36523162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated adrenocorticotropic hormone deficiency associated with sintilimab therapy in a patient with advanced lung adenocarcinoma: a case report and literature review.
    Lin SH; Zhang A; Li LZ; Zhao LC; Wu LX; Fang CT
    BMC Endocr Disord; 2022 Sep; 22(1):239. PubMed ID: 36153581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pembrolizumab- and ipilimumab-induced diabetic ketoacidosis and isolated adrenocorticotropic hormone deficiency: a case report.
    Porntharukchareon T; Tontivuthikul B; Sintawichai N; Srichomkwun P
    J Med Case Rep; 2020 Sep; 14(1):171. PubMed ID: 32988414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: a new case and literature review.
    Oğuz SH; Ünlütürk U; Aksoy S; Erbas T
    Immunotherapy; 2021 Oct; 13(14):1157-1163. PubMed ID: 34387129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report.
    Takeno A; Yamamoto M; Morita M; Tanaka S; Kanazawa I; Yamauchi M; Kaneko S; Sugimoto T
    BMC Endocr Disord; 2019 Feb; 19(1):25. PubMed ID: 30782163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothyroidism With ACTH Deficiency During Pembrolizumab Therapy for Lung Cancer: Case Report and Literature Review.
    Hashinokuchi A; Haro A; Minagawa R; Haruta Y; Kawano H; Suehiro T; Sugimachi K
    Cancer Diagn Progn; 2023; 3(4):498-503. PubMed ID: 37405219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated Adrenocorticotropic Hormone Deficiency Associated with Severe Hyperkalemia During Pembrolizumab Therapy in a Patient with Ureteral Cancer and an Ileal Conduit: A Case Report and Literature Review.
    Hinata Y; Ohara N; Sakurai Y; Koda R; Yoneoka Y; Takada T; Hara N; Nishiyama T
    Am J Case Rep; 2021 Jul; 22():e931639. PubMed ID: 34262010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of Isolated Adrenocorticotropic Hormone Deficiency Caused by Pembrolizumab.
    Bekki T; Takakura Y; Kochi M; Konemori Y; Oki K; Yoneda M; Egi H; Ohdan H
    Case Rep Oncol; 2020; 13(1):200-206. PubMed ID: 32308578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When Hormones are Being Difficult: A Rare Case and the Literature Review of Pembrolizumab-Induced Polyendocrinopathy.
    Tayyeb M; Tariq M; Khan AM; Khalid F; Meghal T; Du D
    J Community Hosp Intern Med Perspect; 2023; 13(6):90-94. PubMed ID: 38596553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated Adrenocorticotropic Hormone Deficiency Secondary to Chronic Opiate Use.
    Raj R; Jacob A; Elshimy G; Smith J
    Cureus; 2020 Jul; 12(7):e9270. PubMed ID: 32821615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
    Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
    J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring a New Entity of Single-Agent Pembrolizumab-Associated Hypophysitis.
    Balti E; Verhaeghe S; Kruse V; Roels S; Coremans P
    Cureus; 2022 Aug; 14(8):e27763. PubMed ID: 36127991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis.
    Thapi S; Leiter A; Galsky M; Gallagher EJ
    J Immunother Cancer; 2019 Sep; 7(1):248. PubMed ID: 31511065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.
    Hanna KS
    Pharmacotherapy; 2016 Nov; 36(11):e183-e188. PubMed ID: 27716999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy Induced Adrenal Insufficiency: An Underdiagnosed Cause of Persistent Hypotension in Cancer.
    Cheng NH; Lee H; Balchander D; Mimms R; Krishnamurthy M
    J Community Hosp Intern Med Perspect; 2024; 14(4):68-70. PubMed ID: 39391114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy-induced isolated ACTH deficiency in cancer therapy.
    Iglesias P; Peiró I; Biagetti B; Paja-Fano M; Cobo DA; García Gómez C; Mateu-Salat M; Genua I; Majem M; Riudavets M; Gavira J; Lamas C; Fernández Pombo A; Guerrero-Pérez F; Villabona C; Cabezas Agrícola JM; Webb SM; Díez JJ
    Endocr Relat Cancer; 2021 Oct; 28(12):783-792. PubMed ID: 34609950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.